H. B. Fuller (FUL) Reports Q2 Earnings: What Key Metrics Have to Say

H. B. Fuller (FUL) reported Q2 revenue of $898.1 million, a 2.1% year-over-year decline, and EPS of $1.18 for the quarter ended May 2025, both narrowly beating analyst consensus estimates. Despite the overall revenue dip, the company saw a 1.1% revenue increase in its Hygiene, Health and Consumable Adhesives segment and delivered stronger-than-expected adjusted EBITDA across both its Engineering and Hygiene, Health and Consumable Adhesives divisions, signaling robust segment profitability. While the stock has underperformed the S&P 500 over the past month, it carries a Zacks Rank #2 (Buy), suggesting potential near-term outperformance.

Analysis

H. B. Fuller (FUL) reported a mixed Q2 performance, characterized by a slight top-line decline but a strong bottom-line beat. Total revenue of $898.1 million decreased 2.1% year-over-year, essentially matching consensus, while EPS of $1.18 surpassed the $1.10 estimate by 7.27% and grew from $1.12 a year ago. A deeper look at key metrics reveals a significant divergence between segments: the Hygiene, Health and Consumable Adhesives division posted modest 1.1% year-over-year revenue growth, but this was more than offset by a substantial 26% revenue collapse in the Engineering Adhesives segment. Despite this top-line weakness, the company demonstrated notable operational strength, as adjusted EBITDA in both segments exceeded analyst expectations, indicating effective margin management. The stock's recent +1.4% return has significantly lagged the S&P 500's +5.1% gain, suggesting investor concern over the revenue picture, even as the company holds a Zacks Rank #2 (Buy).

Key Decisions for Investors

• Investors should closely monitor the revenue trajectory of the Engineering Adhesives segment, as its 26% year-over-year decline represents the primary headwind for the company's growth profile.
• The company's ability to exceed adjusted EBITDA forecasts across its divisions despite revenue challenges signals strong operational efficiency and margin resilience, a key positive to watch in upcoming reports.
• Given the stock's recent underperformance relative to the market, investors should weigh the risk of continued top-line weakness against the demonstrated profitability and positive analyst rating when considering a position.